Literature DB >> 3046540

Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings.

R C Lefebvre1, K G Hursey, R A Carleton.   

Abstract

Screening programs have expanded to identify the many persons who are unaware of their high blood cholesterol level and thus are at an increased risk for coronary heart disease. These programs bring both potential benefits and potential risks to the participant. One potential risk is that of iatrogenic effects of learning one's risk status, often referred to as the "labeling phenomenon." Research that has addressed the labeling phenomenon in blood pressure screening programs has important implications for blood cholesterol screenings. Detrimental effects on screening participants are possible, but they can be attenuated by careful attention to characteristics of the debriefing and counseling that should be included in screening protocols.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046540

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Use of decision aids to support informed choices about screening.

Authors:  Alexandra Barratt; Lyndal Trevena; Heather M Davey; Kirsten McCaffery
Journal:  BMJ       Date:  2004-08-28

2.  Risk assessment in the prevention of coronary heart disease: a policy statement. Coronary Prevention Group.

Authors: 
Journal:  Br J Gen Pract       Date:  1990-11       Impact factor: 5.386

Review 3.  Breast-feeding in a polluted world: uncertain risks, clear benefits.

Authors:  J W Frank; J Newman
Journal:  CMAJ       Date:  1993-07-01       Impact factor: 8.262

4.  The association between annually-repeated health screening and health behavior among company employees.

Authors:  A Hagihara; K Tarumi; K Morimoto
Journal:  Environ Health Prev Med       Date:  1996-07       Impact factor: 3.674

5.  Follow-up study of participants in an extensive health examination programme at a Swedish industry.

Authors:  G Rose; C Bengtsson
Journal:  Klin Wochenschr       Date:  1990-12-30

6.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

7.  Population screening for genetic susceptibility to disease.

Authors:  A Clarke
Journal:  BMJ       Date:  1995-07-01

Review 8.  Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors:  T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

9.  Cholesterol screening and cholesterol lowering treatment.

Authors:  T A Sheldon; F Song; G D Smith; N Freemantle; J Mason; A Long
Journal:  Qual Health Care       Date:  1993-06

10.  Hypertensive labeling: does it have therapeutic implications.

Authors:  W H Birkenhäger
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.